Neal Shore

72PUBLICATIONS
260CO-AUTHORS
Cancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsChemotherapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (72)

|Sep 26, 2026
Trial design drives outcomes: harmonising efficacy across BCG-unresponsive bladder carcinoma in situ trials.

|Jul 09, 2026
Enzalutamide in biochemically recurrent prostate cancer: clinical implications from EMBARK for real-world practice.

|Jun 25, 2026
Real-world clinical outcomes and economic burden of discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer.

|Jun 20, 2026
Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trial.

|Jun 02, 2026
Phase Ib Trial of Bavdegalutamide (ARV-110) in Combination with Abiraterone for Metastatic Prostate Cancer.

|Jun 01, 2026
Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase IIa PLANETTE Study.

Pageof 12

Frequent Collaborators

6 joint publications

Alicia K Morgans

6 joint publications

Fred Saad

5 joint publications

Emmanuel S Antonarakis

5 joint publications

Rana R McKay